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Relationship between serum 25-hydroxyvitamin D
concentration and risks of metabolic syndrome 
in children and adolescents from Korean National 
Health and Nutrition Examination survey 2008–2010
Original article
Purpose: Previous studies have revealed many inconsistent results regarding the 
relationship between vitamin D and metabolic syndrome. The purpose of our study 
was to investigate the association between serum 25-hydroxyvitamin D (25(OH)D) 
concentration and factors that characterize metabolic syndrome in Korean children 
and adolescents.
Methods: We analyzed data from 2,880 children and adolescents aged 10–18 years 
collected from the 2008–2010 Korean National Health and Nutrition Examination 
Survey. We investigated the data according to quartiles of 25(OH)D concentrations. 
Results: Systolic blood pressure and diastolic blood pressure with adjustment for 
sex and age differed significantly between the serum 25(OH)D groups and exhibited 
negative trend as 25(OH)D concentrations increased. The number of subjects with 
metabolic syndrome was greater in the low 25(OH)D groups (I, II, and III quartile) 
than in the high 25(OH)D group (IV quartile) (P=0.029). BMI and waist circumference 
were lower in the high 25(OH)D group. Serum 25(OH)D concentration correlated 
negatively with homeostasis model assessment estimate of insulin resistance (ρ=–
0.073, P<0.001) and correlated positively with quantitative insulin sensitivity check 
index (ρ=0.095, P<0.001). 
Conclusion: Low serum 25(OH)D level is associated with an increase of insulin 
resistance and metabolic syndrome in children and adolescents.
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Introduction
According to recent studies, vitamin D deficiency is common in all ages and has become a 
worldwide health concern1). This condition could be a problem especially in growing children 
because vitamin D plays an important role in bone metabolism and calcium homeostasis1,2). 
Research has shown that vitamin D deficiency is related to musculoskeletal disease, 
cardiovascular disease, type 2 diabetes mellitus, certain types of cancers, and autoimmune 
diseases3-5).
Metabolic syndrome is a cluster of medical disorders that, when manifested altogether, 
increases the risk of developing cardiovascular disease and type 2 diabetes6). Metabolic 
syndrome is characterized by dyslipidemia, glucose intolerance, elevated blood pressure, and 
abdominal obesity7). In particular, insulin resistance (IR) plays a central role in the pathogenesis 
of type 2 diabetes mellitus and other cardiovascular complication8). Obese children have a 
higher risk of IR9). Moreover, studies have shown that obesity is associated with vitamin D 
47
Lee DY, et al. • Relationship between 25-hydroxyvitamin D and metabolic syndrome
www.e-apem.org
deficiency due to decreased bioavailability of the vitamin10,11).
Although research on the relationship between vitamin D 
and metabolic syndrome has increased, many results have been 
inconsistent. Gordon et al.12) reported a negative correlation 
between BMI and serum 25-hydroxy-vitamin D [25(OH)
D] concentration, whereas Baradaran et al.13) showed no 
significant association between these parameters. Studies of the 
relationship between serum vitamin D and metabolic syndrome 
in children are lack. Thus, we investigated the association 
between serum 25(OH)D concentration and the components of 
metabolic syndrome and IR in Korean children and adolescents 
using data obtained from the Korean National Health and 
Nutrition Examination Survey (KNHANES) conducted from 
2008 to 2010.  
Materials and methods
1. Subjects
We used data from the 2008–2010 KNHANES. This cross-
sectional and nationally representative survey was conducted 
by the Division of Chronic Disease Surveillance of the Korean 
Centers for Disease Control and Prevention, which has assessed 
the health and nutritional status of adults and children since 
1998. This study was approved by the Korean Centers for 
Disease Control and Prevention and written informed consents 
were obtained. Also, written informed consents from the next 
of kin, caretakers, or guardians were obtained on behalf of the 
children enrolled in this study. The study was approved by the 
Yonsei University Health System, Gangnam Severance Hospital, 
Institutional Review Board (3–2014–0135). From 2008 to 2010, 
a survey was conducted annually that included 3,656 children 
and adolescents aged 10–18 years. We excluded individuals for 
which data on 25(OH)D was missing (n=721), as well as patients 
with an insufficient blood sample to determine metabolic 
syndrome (n=611). In total, the study population consisted of 
2,880 children and adolescents, of which 1,537 were boys and 
1,343 were girls.
2. Anthropometric and biochemical measurements
The participants’ height, weight, and waist circumferences 
(WCs) were measured to the nearest 0.1 kg using a scale (CAS, 
Seoul, Korea) and 0.1 cm using a stadiometer (SECA-225, 
Hamburg, Germany) by a trained medical examiner. WC was 
measured at the narrowest point between the lower border 
of the rib cage and the iliac crest. Standard deviation scores 
(SDS) of heights, weights, and BMI were calculated using the 
lambda-mu-sigma method. Blood pressure was measured in 
the right arm using a standard mercury sphygmomanometer 
(Baumanometer, W.A. Baum Co., Copiague, NY, USA) after 
the subject had rested for 5 minutes in a sitting position. Two 
systolic and diastolic blood pressure (DBP) readings were 
recorded at 5-minute intervals, and the average was used for 
analysis. 
Blood samples were collected from subjects who had fasted 
overnight. The serum triglyceride, high density lipoprotein 
(HDL) cholesterol, and plasma fasting glucose level were 
measured using a Hitachi Automatic Analyzer 7600 (Hitachi, 
Tokyo, Japan). Serum insulin levels was measured using the 
competitive radioimmunoassay (RIA) method with 1470 
WIZARD equipment (PerkinElmer, Turku, Finland) and serum 
25(OH)D levels were measured with 125I-labelled RIA kits 
(Diasorin, Stillwater, MN, USA) using a gamma-counter (1470 
Wizard; PerkinElmer). IR was evaluated using the homeostasis 
model assessment of  IR (HOMA-IR) index, which was 
calculated as [glucose (mmol/L)×insulin (µU/mL)]/22.5014), 
and the quantitative insulin sensitivity check index (QUICKI), 
which was determined as 1/{log [fasting insulin (µU/mL)]+log 
[fasting glucose (mg/dL)]}15).
3. Definition of metabolic syndrome
Modified National Cholesterol Education Program-Adult 
Treatment Panel III (NCEP-ATP III) criteria was used for 
diagnosis of adolescent metabolic syndrome16). We used a 
cutoff value of 100 mg/dL for fasting glucose as revised by 
the American Diabetes Association in 200317). According to 
these criteria, the diagnosis for metabolic syndrome requires 
the presence of three or more of the following: (1) WC≥90th 
percentile for age and sex, (2) triglycerides≥110 mg/dL, (3) HDL 
cholesterol≤40 mg/dL, (4) either systolic blood pressure (SBP) 
or DBP≥90th percentile for age, sex, and height, (5) or fasting 
glucose≥100 mg/dL. The reference values for WC and blood 
pressure were based on growth charts published by the Korean 
Pediatric Society in 200718).
4. Statistical analysis
SAS 9.2 (SAS Institute Inc., Cary, NC, USA) was used for data 
analysis. The statistical analyses conducted were the Student 
t-test, chi-square test, analysis of variance (ANOVA), analysis 
of covariance (ANCOVA), Mantel-Haenszel test, and partial 
correlation analysis. Children were divided into four subgroups 
according to quartiles of serum 25(OH)D concentration. 
Anthropometric data, each metabolic component, and the 
insulin sensitivity index were compared between the quartile 
groups by ANOVA, ANCOVA and trend analyses. Partial 
correlation analysis was used to obtain the partial correlation 
coefficient between vitamin D and the insulin sensitivity index. 
P<0.05 was considered as statistically significant.
Results
Of the 2,880 subjects included in this study, 1,537 (53.3%) were 
boys and 1,343 (46.7%) were girls. The mean age was 13.74±2.49, 
ranging from 10–18 years. Weight, weight SDS, height, height 
SDS, BMI, WC, SBP, fasting glucose, HDL cholesterol, and 
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QUICKI differed significantly between the sexes. The serum 
25(OH)D concentration and prevalence of metabolic syndrome 
were significantly higher in boys than in girls. The mean serum 
25(OH)D concentration of all participants was 17.42±8.95 ng/
mL (Table 1). 
All subjects were divided into four groups according to 
quartiles of serum 25(OH)D concentration, namely I (<13.10 
ng/mL), II (13.10 to 16.63 ng/mL), III (16.63 to 20.86 ng/mL), 
and IV (≥20.86 ng/mL). SBP, DBP, WC, BMI, HOMA-IR, and 
QUICKI were significantly different and exhibited a consistent 
trend according to the quartile of serum 25(OH)D in the 
analysis with unadjusted data (Table 2).  
When vitamin D deficiency was defined as less than 20 ng/
mL19), most of subjects were vitamin D deficiency except IV 
quartile group. We put together subjects from first quartile group 
to third quartile group and performed analysis of comparison 
with IV quartile group. There were significant difference in 
mean age, SBP, DBP, WC, fasting glucose, BMI, weight, height, 
HOMA-IR and QUICKI between two groups. The occurrence of 
metabolic syndrome was significantly lower in IV quartile group 
(P=0.029) (Table 3).
Finally, the association between serum 25(OH)D level and 
insulin sensitivity index is presented in Table 4. Partial corr-
elation analysis revealed an inverse correlation between serum 
25(OH)D and HOMA-IR (ρ=–0.073) and a positive correlation 
between serum 25(OH)D and QUICKI (ρ=0.095).
Discussion
In this study, we analyzed the relationship between serum 
25(OH)D levels and risk factors for metabolic syndrome in 
Korean children and adolescents using nationally representative 
data collected for 3 years. We tried to show the correlation of 
serum 25(OH)D with not only metabolic component, but also 
insulin sensitivity index. Our study found low serum 25(OH)
D concentrations were related with elevated blood pressure, 
abdominal obesity, increase of insulin resistance, and high 
prevalence of metabolic syndrome.
Several studies have investigated the relationship between 
serum 25(OH)D levels and cardiovascular risk factors, such as 
insulin resistance and abdominal obesity. In a study of 1,660 
nine-year old Korean children, Lee et al.20) found that vitamin 
D deficiency in children may be a risk factor for obesity and 
metabolic syndrome. Reis et al.21) also found that low serum 
vitamin D in United States adolescents aged 12–19 years was 
strongly associated with hypertension, hyperglycemia, and 
metabolic syndrome. These studies showed a consistent trend 
that incidence of metabolic syndrome decreased as serum 
25(OH)D increased.
However, our study showed a different result compared with 
previous study in part. BMI SDS, weight SDS and incidence of 
metabolic syndrome were lower in the first quartile of serum 
25(OH)D group than in the second quartile group. This result 
indicates that people in the first quartile of serum 25(OH)D 
were relatively slimmer than those in the second quartile. In 
obese patients, the ability to produce vitamin D in the skin is 
Table 1. Basic characteristics of the study subjects
Variable Total (n=2,880) Boys (n=1,537) Girls (n=1,343) P-value
Age (yr) 13.74±2.49 13.73±2.50 13.74±2.47 0.871
Weight (kg) 53.21±13.79 56.0±15.1 49.5±11.0 <0.001
Weight SDS 0.18±1.07 0.25±1.06 0.10±1.06 <0.001
Height (cm) 160.18±11.63 163.3±13.0 156.6±8.5 <0.001
Height SDS 0.43±1.03 0.52±1.04 0.33±1.02 <0.001
BMI (kg/m2) 20.46±3.57 20.7±3.7 20.0±3.3 <0.001
BMI SDS –0.00±1.08 0.03±1.09 –0.04±1.07 0.085
Waist circumference (cm) 69.01±9.75 71.1±10.3 66.6±8.4 <0.001
SBP (mmHg) 103.54±10.43 105.1±11.1 101.7±9.3 <0.001
DBP (mmHg) 64.43±8.95 64.6±9.5 64.2±8.2 0.172
Fasting glucose (mg/dL) 89.36±6.55 90.0±6.4 88.7±6.6 <0.001
HDL cholesterol (mg/dL) 49.35±9.19 48.3±9.1 50.5±9.1 <0.001
Triglycerides (mg/dL) 87.14±56.98 85.8±57.1 88.7±56.8 0.170
HOMA-IR 3.03±1.78 2.99±1.83 3.09±1.72 0.135
QUICKI 0.330±0.020 0.331±0.020 0.329±0.019 0.001
BMI≥95th percentile 177 (6.1) 98 (6.4) 79 (5.9) 0.579
25(OH)D (ng/mL) 17.42±8.95 18.10±6.00 16.70±5.50 <0.001
Metabolic syndrome 149 (5.2) 92 (6.0) 57 (4.2) 0.043
P-values were calculated as a comparison between boys and girls.
Values are presented as mean±standard deviation or number (%).
SDS, standard deviation score; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL cholesterol, high density 
lipoprotein cholesterol; HOMA-IR, homeostasis model assessment of insulin resistance index; QUICKI, quantitative insulin sensitivity check index; 
25(OH)D, 25-hydroxyvitamin D. 
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not reduced compared to nonobese patients; however, obesity 
may decrease vitamin D release from the skin and dietary 
sources into the circulation by storing fat-soluble vitamin D in 
subcutaneous fat10). Many researches have demonstrated inverse 
correlation between status of obesity and serum 25(OH)D. 
Our result implies the subjects in first quartile could be affected 
by other factors that were uncontrolled in this study but had 
stronger effect than obesity to decrease serum vitamin D levels, 
such as sun exposure time, whether sunblock use or not, amount 
of vitamin D intake, life style, and so on. Especially, sun exposure 
is critical factor to synthesize endogenous vitamin D. However, 
our study could not consider and control these factors. 
Another reason for the discrepancy with previous result 
may be a low prevalence of obesity in Korean children and 
adolescents. When obesity was defined beyond the 95th 
percentile by sex and age, 16.9% of United States children and 
adolescents aged 2–19 years were found to be obese in 2009–
201022), whereas the prevalence of obesity among participants 
was only 6.1% in this study. In the study of Reis et al.21), they 
compared BMI according to quartiles of serum 25(OH)D in the 
same manner, and from the first quartile to the fourth quartile, 
BMI values were 26.0, 24.3, 23.5, and 22.1, respectively. These 
values were higher than our results which were 20.78, 20.69, 
20.55, and 19.82. Populations with a low prevalence of obesity 
may be obscuring the relationship between serum vitamin D 
and metabolic syndrome23).
Table 2. Factors of metabolic syndrome, anthropometric indices, and insulin sensitivity index according to quartiles of serum 25(OH)D 
concentration
Variable
Quartile of serum 25(OH)D (ng/mL), mean (95% CI)
P-valuea) P for trenda) P-valueb) P for trendb)I
(<13.10)
II
(≥13.10 to <16.63)
III
(≥16.63 to <20.86)
IV
(≥20.86)
No. of subjects 
  (total=2,880)
720 717 723 720
Metabolic syndrome 41 (5.7) 46 (6.4) 36 (5.0) 26 (3.6) - 0.0375 - -
Age 14.78
(14.61–14.95)
13.96
(13.78–14.14)
13.39
(13.21–13.57)
12.82
(12.64–12.99)
<0.001 <0.001 - -
Male sex 341 (47.4) 336 (46.9) 410 (56.7) 450 (62.5) <0.001 <0.001 - -
SBP (mmHg) 104.92
(104.15–105.68)
103.89
(103.11–104.66)
103.30
(102.53–104.07)
102.05
(101.32–102.78)
<0.001 <0.001 0.017 0.002
DBP (mmHg) 66.45
(65.78–67.12)
65.12
(64.49–65.75)
63.76
(63.13–64.39)
62.40
(61.75–63.05)
<0.001 <0001 <0.001 <0.001
Waist circumference 
  (cm)
70.00
(69.30–71.71)
69.47
(68.72–70.22)
69.06
(68.34–69.78)
67.52
(66.86–68.18)
<0.001 <0.001 0.043 0.126
Fasting glucose
  (mg/dL)
89.28
(88.80–89.77)
89.21
(88.74–89.69)
89.01
(88.53–89.49)
89.93
(89.46–90.41)
0.045 0.111 0.002 0.004
HDL cholesterol 
  (mg/dL)
49.38
(48.69–50.07)
49.06
(48.39–49.73)
49.18
(48.52–49.85)
49.78
(49.12–50.45)
0.464 0.381 0.398 0.887
Triglycerides
  (mg/dL)
85.28
(81.55–89.02)
91.00
(85.82–96.17)
86.76
(82.98–90.54)
85.54
(81.72–89.36)
0.199 0.715 0.205 0.488
BMI (kg/m2) 20.78
(20.51–21.04)
20.69
(20.41–20.96)
20.55
(20.29–20.81)
19.82
(19.58–20.06)
<0.001 <0.001 0.005 0.100
BMI SDS –0.05
(–0.13 to 0.03)
0.04
(–0.04–0.12)
0.07
(0.00–0.15)
–0.07
(–0.14 to 0.01)
0.029 0.944 0.016 0.224
Weight (kg) 56.17
(55.20–57.14)
54.24
(53.19–55.29)
52.97
(51.96–53.99)
49.45
(48.51–50.40)
<0.001 <0.001 <0.001 0.002
Weight SDS 0.14
(0.06–0.22)
0.22
(0.17–0.29)
0.26
(0.18–0.33)
0.12
(0.04–0.19)
0.045 0.8687 0.006 0.033
Height (cm) 163.7
(163.0–164.4)
160.8
(160.0–161.7)
159.43
(158.6–160.3)
156.8
(155.9–157.7)
<0.001 <0.001 <0.001 <0.001
Height SDS 0.44
(0.36–0.52)
0.42
(0.34–0.49)
0.46
(0.39–0.54)
0.40
(0.33–0.48)
0.701 0.729 0.04 0.008
HOMA-IR 3.03
(2.89–3.18)
3.18
(3.04–3.32)
3.04
(2.93–3.15)
2.88
(2.76–3.01)
0.020 0.048 <0.001 <0.001
QUICKI 0.330
(0.329–0.332)
0.328
(0.326–0.330)
0.329
(0.328–0.331)
0.332
(0.331–0.334)
<0.001 0.035 <0.001 <0.001
25(OH)D, 25-hydroxyvitamin D; CI, confidence interval; SDS, standard deviation score; SBP, systolic blood pressure; DBP, diastolic blood 
pressure; HDL cholesterol, high density lipoprotein cholesterol; BMI, body mass index; HOMA-IR, homeostasis model assessment of insulin 
resistance index; QUICKI, quantitative insulin sensitivity check index. 
a)P-value was analyzed using analysis of variance and trend analyses. b)P-value was analyzed using analysis of covariance and trend 
analyses with adjustments for sex and age.
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Holick et al.19) divided children into 3 group according to 
serum 25(OH)D concentrations; deficiency (less than 20 ng/
mL), insufficiency (21–29 ng/mL), sufficiency (more than 30 
ng/mL). Most of subjects belonging to I–III quartile group were 
vitamin D deficiency, and most of subjects in the IV quartile 
group were insufficiency. Vitamin D sufficiency was only 3.1% 
and this result is consistent with other research20). 
In the comparison of two group, the number of subjects with 
metabolic syndrome was greater in the low 25(OH)D groups 
(I, II, and III quartile) than in the high 25(OH)D group (IV 
quartile). In addition, BMI and WC were significantly lower in 
the IV quartile group. These results suggest low serum vitamin 
D concentration is a risk factor of obesity and metabolic 
syndrome.
Some studies have investigated the correlation between 
serum 25(OH)D concentration and insulin sensitivity24,25). 
Vitamin D has been shown to enhance insulin sensitivity 
directly by stimulating insulin receptor expression and insulin 
responsiveness for glucose transport26). Also, vitamin D has an 
indirect effect by regulating extracellular calcium concentration 
and influx through cell membranes, because calcium is 
essential for insulin-mediated intracellular processes in insulin-
responsive tissue27). Consistent with this study, our data shows 
a significant association with two types of insulin sensitivity 
index and serum 25(OH)D. Since insulin resistance is a key 
mechanism of metabolic syndrome, the result that low vitamin 
D has been correlated with increase of insulin resistance is a 
conclusive evidence to support vitamin D deficiency is a risk 
factor of metabolic syndrome.
Our data also showed that age was negatively correlated 
with the serum 25(OH)D level. Few studies have reported 
an association between serum 25(OH)D and age. Kim et 
al.28) reported that senior high school students exhibit a high 
proportion of vitamin D deficiency compared with elementary 
school children. Another study reported that adolescents 
possess low vitamin D levels compared with young children29). 
One possible cause is that most Korean middle and high school 
students spend the majority of the daylight hours in school and 
private institutes without exercise and outdoor physical activity. 
In such environments, adolescents could not receive enough 
Table 3. Comparison of factors of metabolic syndrome, anthropometric indices, and insulin sensitivity index between serum 25(OH)D 
quartile I–III groups and quartile IV group
Variable
Serum 25(OH)D concentration (ng/mL)
P-value
Quartile I–III (<20.86) Quartile IV (≥20.86)
No. of subjects (total=2,880) 2,160 720
Male sex 1,087 (50.3) 450 (62.5) <0.001
Age (yr) 14.04±2.45 12.82±2.36 <0.001
SBP (mmHg) 104.03±10.53 102.05±9.98 <0.001
DBP (mmHg) 65.11±8.86 62.40±8.92 <0.001
Waist circumference (cm) 69.51±9.92 67.52±9.07 <0.001
Fasting glucose (mg/dL) 89.17±6.56 89.93±6.51 0.007
HDL cholesterol (mg/dL) 49.21±9.22 49.78±9.11 0.145
Triglycerides (mg/dL) 87.67±58.48 85.54±52.23 0.384
BMI (kg/m2) 20.67±3.64 19.82±3.28 <0.001
BMI SDS 0.022±1.099 –0.067±1.021 0.057
Weight (kg) 54.46±13.87 49.45±12.86 <0.001
Weight SDS 0.205±1.080 0.118±1.020 0.057
Height (cm) 161.3±11.2 156.8±12.2 <0.001
Height SDS 0.440±1.034 0.403±1.032 0.414
HOMA-IR 3.08±1.80 2.88±1.71 0.010
QUICKI 0.329±0.198 0.332±0.020 <0.001
Metabolic syndrome 123 (5.7) 26 (3.6) 0.029
P-value was calculated as a comparison between quartile I–III groups and quartile IV group.
Values are presented as number (%) or mean±standard deviation.
25(OH)D, 25-hydroxyvitamin D; SBP, systolic blood pressure; DBP, diastolic blood pressure; SDS, standard deviation score; HDL cholesterol, high density 
lipoprotein cholesterol; BMI, body mass index; HOMA-IR, homeostasis model assessment of insulin resistance index; QUICKI, quantitative insulin 
sensitivity check index.  
Table 4. Partial correlation between serum 25(OH)D and insulin sensitivity index
Variable ρa) (95% CI) P-value ρb) (95% CI) P-value
HOMA-IR –0.047 (–0.083 to –0.011) 0.012 –0.073 (–0.103 to –0.039) <0.001
QUICKI 0.055 (0.019–0.091) 0.003 0.095 (0.056–0.132) <0.001
25(OH)D, 25-hydroxyvitamin D; CI, confidence interval; HOMA-IR, homeostasis model assessment of insulin resistance index; QUICKI, quantitative 
insulin sensitivity check index; BMI, body mass index; SDS, standard deviation score.
a)Unadjusted for sex, age, and BMI SDS. b)Adjusted for sex, age, and BMI SDS.
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sunlight to synthesize vitamin D. Increased use of sunscreen and 
consumption of less than the recommended levels of vitamin 
D in adolescents are also thought to be causes for lower serum 
25(OH)D levels in high school students28).
This study has some limitations. First, causality could not 
be determined because this study was cross-sectional design. 
Second, other factors that affect serum vitamin D level were 
not evaluated in this study, including dietary vitamin D, 
calcium intake, and outdoor physical activity time, parathyroid 
hormone, which plays an important role in calcium homeostasis 
and serum vitamin D level. Third, age- and sex-related factors, 
such as lifestyle and diet, were not adjusted even though we 
adjusted age and sex in the statistics. Such confounding factors 
may affect the result that individuals in the first quartile of 
25(OH)D presented lower BMI SDS, weight SDS, and incidence 
of metabolic syndrome than those in the second quartile. To 
confirm the effect of vitamin D status on metabolic syndrome, 
especially in children and adolescents, a well-designed 
longitudinal study is needed after adjusting for controllable 
factors.
In summary, our study demonstrates that low serum 25(OH)
D level is associated with an increase of insulin resistance and 
metabolic syndrome in children and adolescents. Additional 
well designed longitudinal research is needed to reveal long 
term effect and causality between vitamin D status and 
metabolic syndrome.
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